Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Leidschendam
Clinical trial register · Netherlands

Clinical Trials in Leidschendam, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3175 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:17 UTC
3175
Studies in scope
all four open statuses
1789
Recruiting now
open to new participants
601
Lead sponsors
across recruiting studies
Top sites
Amsterdam 1243 Rotterdam 855 Groningen 601 Nijmegen 565 Utrecht 545

Trials with a site in Leidschendam

15 of 3175 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Not yet open
Leiden University Medical Center
Observational
100
Leiden, Leidschendam, The Hague
2026-12
Recruiting
AstraZeneca
Phase 3
1,160
Alkmaar, Ede, Groningen, Leidschendam, Veldhoven
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Alkmaar, Ede, Groningen, Leidschendam, Veldhoven, Zwolle
2024-11-18
Active, closed
Hoffmann-La Roche
Phase 3
338
's-Hertogenbosch, Arnhem, Breda, Harderwijk, Leidschendam, Zwolle
2024-09-23
Recruiting
Towards Optimal Treatment for High Risk Prostate Cancer
NCT06204341High Risk Prostate Carcinoma
Haaglanden Medical Centre
Not applicable
207
Leidschendam
2024-01-02
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Almere Stad, Amsterdam, Arnhem, Leidschendam, Rotterdam, Utrecht, Venlo
2023-12-15
Recruiting
Haaglanden Medical Centre
Not applicable
130
Leidschendam
2022-07-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Nijmegen, Maastricht, 's-Hertogenbosch, Tilburg, Amsterdam, Leiden, Leidschendam, Schiedam
2021-06-18
Recruiting
Catharina Ziekenhuis Eindhoven
Phase 3
364
Amsterdam, Eindhoven, Groningen, Leiden, Leidschendam, Maastricht, Rotterdam
2020-11-13
Active, closed
Institut de Recherches Internationales Servier
Phase 3
331
Leidschendam, Rotterdam, Utrecht
2020-01-05
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
150
Amsterdam, Deventer, Groningen, Leeuwarden, Leidschendam, Nijmegen, Rotterdam
2019-08-01
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Amsterdam, Groningen, Leidschendam, Nieuwegein, Nijmegen, Rotterdam, Sittard-Geleen
2019-01-25
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Alkmaar, Eindhoven, Hoofddorp, Leidschendam, Nijmegen, Rotterdam
2013-10-14
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-netherlands/city/leidschendam

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,175 studies in total at the last sync on 13 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Leidschendam.

How many clinical trials are recruiting in Leidschendam?

7 of the 15 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Leidschendam), 15 studies
PhaseStudiesRecruitingShare
Phase 311573.3%
Not applicable2213.3%
Observational106.7%
Phase 2106.7%

Most active sponsors

Lead sponsors with the most studies (Leidschendam)
Lead sponsorStudiesRecruiting
AstraZeneca22
European Organisation for Research and Treatment of Cancer - EORTC21
Haaglanden Medical Centre22
Hoffmann-La Roche21
Aragon Pharmaceuticals, Inc.10
Catharina Ziekenhuis Eindhoven11
Incyte Corporation10
Institut de Recherches Internationales Servier10
Janssen Research & Development, LLC10
Leiden University Medical Center10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.